AdetokunboOluwasanjoMD
Oncology • North Wales, PAMedical Director - Early Development, Oncology The Janssen Pharmaceutical Companies of Johnson&Johnson
Dr. Oluwasanjo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 McKean Rd
Spring House
North Wales, PA 19477- Is this information wrong?
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2016 - 2019
Tower HealthResidency, Internal Medicine, 2010 - 2013
University of IbadanClass of 2005
Certifications & Licensure
TX State Medical License 2019 - 2025
PA State Medical License 2013 - 2024
FL State Medical License 2019 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsPeripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).Adetokunbo Folashade Oluwasanjo, Saritha Kartan, William T. Johnson, Onder Alpdogan, Alejandro A. Gru, Anjali Mishra, Bradley M. Haverkos, Jerald Z. Gong, Pierluigi Porcu> ;Cancer Treatment and Research. 2019 Jan 1
- 7 citationsTherapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancerAdetokunbo Oluwasanjo, Ranjan Pathak, Anene Ukaigwe, Olatunji B. Alese> ;Cancer Causes & Control. 2016 Jan 1
- Vital Signs.Adetokunbo Oluwasanjo> ;Academic Medicine. 2015 Dec 1
- Join now to see all
Hospital Affiliations
HCA Florida Lake City HospitalLake City, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
